An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC) (NCT03301506)
ASSURE
This trial is No longer recruiting
Registration number NCT03301506
Program & service
This trial is being run with the Specialty Medicine service, and as part of the Gastroenterology program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Professor Stuart Roberts
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR